Related Experiment Video
Updated: Apr 28, 2026

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates
Published on: May 14, 2019
Folded small molecule manipulation of islet amyloid polypeptide
Sunil Kumar1, Mark A Brown1, Abhinav Nath1
1Department of Molecular Biophysics and Biochemistry, Yale University, 260 Whitney Avenue, New Haven, CT 06520-8114, USA.
Researchers developed oligoquinolines to inhibit islet amyloid polypeptide (IAPP) aggregation, a key factor in diabetes. These compounds stabilize IAPP, preventing toxic amyloid formation and β cell dysfunction.
Area of Science:
- Biochemistry
- Molecular Biology
- Diabetes Research
Background:
- Islet amyloid polypeptide (IAPP) is co-secreted with insulin by pancreatic β cells.
- IAPP aggregation into amyloid structures contributes to β cell dysfunction and diabetes pathology.
- Understanding IAPP's interaction with lipid bilayers is crucial for therapeutic development.
Purpose of the Study:
- To investigate the mechanism of IAPP self-assembly and its interaction with lipid bilayers.
- To design and evaluate novel inhibitors of IAPP aggregation.
- To explore the potential of foldamer scaffolds for protein conformational control.
Main Methods:
- Design and synthesis of substituted oligoquinolines.
- Studies on IAPP self-assembly in solution and in the presence of phospholipid bilayers.
- Analysis of oligoquinoline-induced conformational changes in IAPP.
Main Results:
- Oligoquinolines effectively inhibit IAPP self-assembly in both solution and lipid bilayer environments.
- Inhibitory activity correlates with the oligoquinoline's ability to adopt a stable, noncovalent fold.
- Oligoquinolines demonstrate potential for conformational manipulation of disordered protein states.
Conclusions:
- Compact foldamer scaffolds, like oligoquinolines, represent a promising strategy for controlling protein conformational states.
- Oligoquinolines offer a novel therapeutic avenue for mitigating IAPP-related cytotoxicity in diabetes.
- This work provides mechanistic insights into IAPP aggregation and its modulation.
Related Concept Videos
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Production of Pharmaceuticals
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

